Valuation: Pfizer Inc.

Market Cap 174B 155B 142B 130B 243B 16,506B 249B 1,699B 686B 8,695B 653B 639B 27,471B P/E 2026 *
18.8x
P/E 2027 * 15x
Enterprise Value 222B 198B 182B 166B 311B 21,072B 317B 2,169B 876B 11,100B 833B 816B 35,069B EV / Sales 2026 *
3.57x
EV / Sales 2027 * 3.6x
Free-Float
59.05%
Yield 2026 *
5.64%
Yield 2027 * 5.69%
1 day+1.30%
1 week+2.13%
Current month+0.49%
1 month+9.07%
3 months+22.63%
6 months+16.48%
Current year+23.17%
1 week 29.22
Extreme 29.22
31.04
1 month 27.12
Extreme 27.12
31.04
Current year 23.62
Extreme 23.62
31.04
1 year 23.62
Extreme 23.62
31.04
3 years 20.92
Extreme 20.915
31.54
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 55 2026-08-15
Compliance Officer 65 2013-11-30
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/15/26 Free

Chief Executive Officer

20 0.0000%
10/13/26 Free

Chief Executive Officer

71 0.0000%
9/30/26 Free

Chief Executive Officer

21 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%+2.13%+24.42%+0.52% 174B
-0.46%+10.80%+63.52%+154.48% 1,263B
-0.97%+2.56%+43.25%+81.96% 658B
-2.05%+1.12%+32.47%+102.74% 521B
-1.54%+1.61%+53.42%+67.10% 391B
-0.78%+2.13%+72.55%+44.25% 369B
-1.69%+2.75%+32.49%+54.35% 307B
-0.72%+8.08%+11.15%+34.09% 290B
-0.12%+5.96%+55.97%+78.44% 252B
-0.21%+9.16%+42.19%+112.41% 212B
Average -0.41%+5.47%+43.14%+73.03% 443.59B
Weighted average by Cap. -0.38%+6.40%+48.18%+93.62%

Financials

2026 *2027 *
Net sales 62.23B 55.63B 50.95B 46.42B 87.02B 5,905B 88.93B 608B 245B 3,111B 233B 229B 9,828B 59.89B 53.53B 49.03B 44.67B 83.74B 5,683B 85.58B 585B 236B 2,994B 225B 220B 9,458B
Net income 8.89B 7.94B 7.28B 6.63B 12.43B 843B 12.7B 86.82B 35.04B 444B 33.35B 32.65B 1,404B 11.09B 9.91B 9.08B 8.27B 15.51B 1,052B 15.85B 108B 43.72B 554B 41.61B 40.73B 1,751B
Net Debt 48.12B 43.01B 39.39B 35.89B 67.28B 4,566B 68.76B 470B 190B 2,405B 181B 177B 7,599B 41.54B 37.13B 34.01B 30.99B 58.08B 3,942B 59.36B 406B 164B 2,076B 156B 153B 6,560B
Projected Income Statement - Annual - Pfizer Inc.
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
75,000
Date Price Change Volume
26-11-02 US$30.67 +0.49% 49,599,018
26-10-30 US$30.52 +1.90% 45,485,398
26-10-29 US$29.95 +1.70% 34,259,421
26-10-28 US$29.45 -1.17% 27,260,375
26-10-27 US$29.80 +0.03% 25,592,917
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Pfizer Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
30.67USD
Average target price
29.26USD
Spread / Average Target
-4.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Pfizer Inc.